Dr. Abdul Majid, Ph.D., is a Postdoctoral Research Associate in the Department of Physiology at the University of Tennessee Health Science Center (UTHSC), Memphis, Tennessee, USA. He obtained his Ph.D. in Biochemistry from the University of Mysore, India, conducting his doctoral research at the CSIR–Central Food Technological Research Institute (CFTRI). His research interests encompass cardiovascular and neurological disorders, molecular pharmacology, calcium signaling, mitochondrial bioenergetics, oxidative stress, and neuroinflammation. His current research focuses on the therapeutic potential of sarco/endoplasmic reticulum Ca²⁺-ATPase (SERCA) activation in ischemic stroke, traumatic brain injury, and diabetic cardiomyopathy, with an emphasis on identifying novel molecular targets and therapeutic strategies. Dr. Majid has authored and co-authored peer-reviewed research articles in cardiovascular sciences, neuroscience, and metabolic disorders. He actively serves as a peer reviewer for international scientific journals and is a Senior Collaborator of the Global Burden of Disease (GBD) Study, contributing to global epidemiological research. His broader scientific interests include translational medicine, drug discovery, and the development of therapeutic interventions for cardiovascular, neurological, and metabolic diseases.